Biotech

All Articles

Editas exploit Tip Cas9 licensing rights for $57M

.Against the background of a Cas9 license war that refuses to die, Editas Medicine is moneying in a ...

Ultragenyx fine-tunes genetics treatment dosing to call up effectiveness

.A minority of clients taking Ultragenyx Pharmaceutical's Wilson disease gene therapy UX701 have gon...

Biopharma discharge rate stabilizes in Q3: Tough Biotech study

.As summer months warm relies on cool winds, really hopes that this year would certainly take extens...

J &amp J loses phase 2 dengue applicant in most up-to-date shift from vaccines

.Johnson &amp Johnson's deprioritization of its own contagious ailment pipeline has actually profess...

Relay loses 10% of personnel after earlier layoffs in July

.Precision medication biotech Relay Therapeutics is actually shedding around 10% of its own staff in...

Pentixapharm ratings $22M IPO to deposit radiopharma tests

.Pentixapharm has actually generated just about 20 million europeans ($ 22 thousand) from an IPO, wi...

Lundbeck touches Charles Stream for AI-enabled neuro medication finding

.Lundbeck has tapped Charles Waterway Laboratories' artificial intelligence capacities to help the i...

Big pharma, biotech 'will not essentially be actually symbiotic' in AI: S&ampP

.Huge Pharma is actually investing heavily in AI to slash advancement timetables and also foster adv...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Bio has actually roped in $115 million in collection B funds to advance preclinical antitox...

IGM pivots coming from cancer cells to autoimmune, shocking C-suite

.IGM Biosciences ended in 2015 giving up staff and simplifying its own cancer cells pipeline. Curren...